What are barriers to pharmacogenomics (PGx) clinical uptake?
Ichiro
I
Ieiri
D001711:Biotransformation; D004348:Drug Labeling; D019317:Evidence-Based Medicine; D005838:Genotype; D006801:Humans; D007564:Japan; D010597:Pharmacogenetics / Q000193:education*; D010601:Pharmacology, Clinical / Q000193:education*; D057285:Precision Medicine; D055553:Prescription Drugs / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000494:pharmacology
D055553:Prescription Drugs